scorecardresearch
Monday, August 18, 2025
TopicBharat Biotech

Topic: Bharat Biotech

Early orders, more funds, swift payments — govt panel tips for boosting India’s vaccine supply

According to report by inter-ministerial panel, Bharat Biotech could double its production capacity soon while Serum Institute of India is still looking for ways to expand production.

Bharat Biotech’s Covaxin production could go up 7 times with help from Karnataka, Gujarat labs

Plan to increase Covaxin production being overseen by 6-member inter-ministerial panel appointed to augment vaccine manufacturing as Covid cases see a second wave in India.

Prioritise Covid vaccine supplies within India over exports, govt tells Serum & Bharat Biotech

Health ministry officials say there is no ban on exports but govt is expanding the vaccination drive for which India needs more vaccines for domestic consumption. 

Expert panel recommends Covaxin for emergency use, moves out of ‘clinical trial mode’

The recommendations were made after analysis of interim data of the phase-3 clinical trial of Bharat Biotech's Covaxin's showed the efficacy of the vaccine to be 80.6%.

Delhi HC asks Serum Institute, Bharat Biotech to reveal Covid vaccine manufacturing capacity

The high court also asked the Centre to explain in affidavit the rationale behind keeping strict control over class of persons who can be vaccinated against Covid.

Covaxin shows 81% interim efficacy in preventing Covid, Bharat Biotech says

Bharat Biotech's phase-3 trial was conducted on 25,800 participants between 18-98 years of age, including 2,433 over the age of 60 and 4,500 with comorbidities.

PM Modi taking Covid shot powerful example, will reduce vaccine hesitancy — Bharat Biotech

Bharat Biotech chairman and MD Krishna Ella also expressed gratitude to PM Modi for reposing trust in the indigenously developed Covaxin.

Top WHO official backs Covaxin, says evidence maybe limited but India has every right to approve

Covaxin is one of two vaccines being administered as part of India’s Covid vaccination drive. It was given conditional emergency-use nod in absence of complete Phase 3 trial data.

How Bharat Biotech & Covaxin got caught in a swirl of controversy

Minutes from Jan meetings showed that India’s drug regulatory agency insisted on seeing efficacy data for Covaxin, before approving it for a restricted use in 'clinical trial mode'.

17% Indians in 30-69 age group may not be able to take Covaxin as they’re on blood thinner

Covaxin is contraindicated for people who use blood thinners, while Covishield asks recipients to inform physician. But doctors say there’s no rationale.

On Camera

History teaching requires revision more than textbooks

The kinds of revisions we’re seeing remove the very skills that make historical thinking meaningful. The result is a citizen who either dismisses history entirely or defends it without support.

Navigating Trump’s tariffs is no child’s play. Indian toymakers are losing out on orders, enquiries

Indian toymakers are now exploring new markets, but they want govt to negotiate a trade deal with US soon, introduce incentives and subsidies to make the industry more competitive.

What is Project Sudarshan Chakra, announced by Modi from ramparts of Red Fort

The project is meant to be a ‘protective shield that will keep expanding’, the PM said. It is on the lines of the ‘Golden Dome’ announced by Trump, it is learnt.

War of IAF, PAF doctrines: As Pakistan obsesses over numbers, India embraces risk, wins

Now that both IAF and PAF have made formal claims of having shot down the other’s aircraft in the 87-hour war in May, we can ask a larger question: do such numbers really matter?